B+L launches PureVision2 Multi-Focal

Article

Bausch + Lomb introduced PureVision2 Multi-Focal (balafilcon A) monthly silicone hydrogel multifocal contact lenses at the American Academy of Optometry meeting. Featuring a next-generation 3-zone progressive design, these lenses are designed to improve near and intermediate vision while providing excellent distance clarity.

 

Seattle-Bausch + Lomb introduced PureVision2 Multi-Focal (balafilcon A) monthly silicone hydrogel multifocal contact lenses at the American Academy of Optometry meeting. Featuring a next-generation 3-zone progressive design, these lenses are designed to improve near and intermediate vision while providing excellent distance clarity.

The lens design allows for a more predictable, quick fit for the eyecare professional. According to the company, PureVision2 Multi-Focal helped maintain clear near, intermediate, and distance vision in real-world conditions.

The lenses are approved for extended wear up to 30 days in powers ranging from +6.00 D to –10.00 D in 0.25 D steps. Low add power helps patients needing 0.75 D to 1.50 D of near power, while the high add power addresses needs of 1.75 D to 2.50 D. Base curve is 8.6 mm, and diameter is 14.0 mm.

“We know that consistent, crisp, clear vision at all distances can be a challenge for people with presbyopia. These new lenses will provide that consistency whether viewing a screen on your mobile phone or a screen at the cinema,” said Joseph Barr, OD, MS, vice president, Medical Affairs, Pharmaceuticals, Vision Care, Bausch + Lomb. “We’re optimistic that the combination of a streamlined fit and a satisfied patient will make this lens a favorite for the eyecare professional.”

 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.